TENTANG EPISODE INI
In this episode of Cholesterol Conversations, Drs. Marc Bonaca, Pam Taub, and Heather Johnson discuss how multiagent therapy can improve the provision of care in the real world. Covered topics include new data from the 2023 ACC Scientific Sessions on the efficacy of novel agents and the role of combination therapy, as well as the importance of shared decision-making and keys to managing high-risk populations.
Inggris
Amerika Serikat
DALAM EPISODE INI
TRANSKRIP 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
CARI EPISODE TERDAHULU
Cari episode sebelumnya dari Cholesterol Conversations.
EPISODE LAIN DALAM PODCAST INI
In this episode of Cholesterol Conversations, host Dr. Heather Johnson, Director of Preventive Cardiology for Women's Services at the Christine E. Lynn Women's Health & Wellness Institute of Baptist Health South Florida, sits down with Dr. Viet T. Le, Associate Professor of Research and Co-Dire…
In this episode of Cholesterol Conversations, join Drs. Neha Pagidipati, Christie Ballantyne, and Gregory Piazza for a roundtable discussion that addresses recent guidance on ASCVD management, current gaps in ASCVD care, patient barriers to LDL-C lowering, and nonstatin therapies to consider for pa…
Your patient's LDL-C is still above goal. What should you do next? Dr. Heather Johnson and Professor Viet Le put the 2026 dyslipidemia guidelines into clinical context and discuss how to use PREVENT-ASCVD, lipoprotein(a), and other risk markers to tailor treatment, set LDL goals, and determine when…
Sanggahan: Podcast dan karya seni yang disematkan pada halaman ini berasal dari Vasculearn Network, yang merupakan milik pemiliknya dan tidak berafiliasi atau didukung oleh Listen Notes, Inc.
Sunting
Terima kasih telah membantu agar basis data podcast tetap terbaru
